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Background: Preeclampsia and eclampsia, which are the most frequent hypertensive disorders in pregnancy, are
associated with renal involvements. We aimed to assess the time trend in blood pressure levels, renal function and
proteinuria after delivery, and investigate their determinants in Cameroonian women with severe preeclampsia and
eclampsia.
Methods: This was a prospective cohort study involving 54 women with severe preeclampsia and eclampsia,
conducted between July 2010 and February 2012 at the central maternity unit of the Yaoundé Central Hospital.
Clinical and laboratory parameters were recorded from day-1 to 6 months after delivery. Mixed-linear and logistic
regression models were used to relate baseline and within follow-up levels of covariates, with changes in blood
pressure levels, renal function and proteinuria, as well as persisting hypertension, renal failure and proteinuria.
Results: During follow-up, a significant improvement was observed in blood pressure, renal function and proteinuria
(all p < 0.002). Thirteen (24.1%) patients with renal failure at delivery recovered completely within six weeks. Twenty-six
(48.1%), 17 (31.5%) and 1 (1.8%) patients had persisting proteinuria at 6 weeks, 3 months and 6 months post-delivery,
respectively. Corresponding figures for persisting hypertension were 23 (42.6%), 15 (27.8%) and 8 (14.8%). Advanced
age, higher body mass index, low gestational age at delivery, low fetal birth weight, and proteinuria at delivery were
the main risk factors for persisting hypertension at 3 months, meanwhile low fetal birth weight, severe preeclampsia
and proteinuria at delivery were correlated with persisting proteinuria at 3 months. Advanced age and higher body
mass index were the only determinants of the composite outcome of persisting hypertension or proteinuria at three
and six months.
Conclusion: Hypertension and proteinuria are very common beyond the postpartum period in Cameroonian women
with severe preeclampsia and eclampsia. Long-term follow-up of these women will help preventing and controlling
related complications.
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Hypertensive disorders in pregnancy are a leading cause
of maternal and perinatal morbidity and mortality world-
wide, accounting for up to 25% of maternal deaths [1,2].
Preeclampsia and eclampsia, the most frequent hyperten-
sive disorders, complicate approximately 5% of all pregnan-
cies and account for up about 17% of maternal deaths and
12% of perinatal mortality [3-6].
Preeclampsia and eclampsia are pregnancy specific
conditions with varying clinical features and associated
multiple organs involvement. Both account for a third of
acute kidney injury occurring in advanced pregnancy,
with high risks of progression to end-stage renal disease
(ESRD) [7-12]. The renal involvement in preeclampsia
and eclampsia comprises a glomerular endotheliosis which
is characterized by proteinuria and renal failure. After de-
livery, hypertension, proteinuria and renal failure are ex-
pected to resolve progressively [13]. However, hypertension
and proteinuria can persist for years after delivery, necessi-
tating further investigations for possible underlying renal
disease [13-17]. Meanwhile, renal failure highly correlates
with blood pressure levels and renal function usually as-
sumes the normal range within postpartum [18].
High prevalence of preeclampsia and eclampsia related
complications and risk factors have been reported among
African women [2,15,19]. However, follow-up of women
after delivery has been less-than-optimal in most studies.
Where the follow-up has been successfully conducted, the
nephrological evaluation has received only little attention,
despite the high burden of ESRD in Sub-Saharan Africa
setting. Therefore, knowledge of the long-term outcomes
of preeclampsia and eclampsia among African women re-
mains very limited.
This cohort study was conducted to monitor the time-
trend in blood pressure levels, renal function and pro-
teinuria up to six months after delivery in African
women with severe preeclampsia and eclampsia. Add-
itionally, we investigated the factors associated with per-
sisting hypertension, renal failure and/or proteinuria
during follow-up.
Methods
Study setting
This was a prospective cohort study involving women
with severe preeclampsia and eclampsia, conducted be-
tween July 2010 and February 2012 at the central mater-
nity unit of the Yaoundé Central Hospital, Cameroon.
This was part of a study on hypertensive disorders in
pregnancy carried out in the central maternity unit dur-
ing this study period. The central maternity unit of the
Yaoundé Central Hospital is one of the referral center for
obstetrical conditions for the Capital city of Cameroon
(Yaoundé) and surrounding areas. On a monthly basis, it
provides antenatal care to about 500 pregnant women andperforms on average 300 deliveries. The staffs of this unit
comprise 10 gynecologists/obstetricians and 61 nurses. It is
also a teaching unit for specialist obstetricians and gynecol-
ogists in training, as well as undergraduate medical stu-
dents of the Yaoundé School of medicine. This study was
approved by the Cameroon National Ethics Committee.
All participants or their next-of-kin provided written in-
formed consent before enrollment in the study.
Data collection
Included participants were pregnant women with severe
preeclampsia or eclampsia, who had attended at least
three antenatal visits, and who subsequently delivered at
the central maternity unit of the Yaoundé Central Hos-
pital. These visits had to have been accrued within the
last three months preceding the pregnancy and before
the 20th week of gestation. We excluded from the study,
women with a known history of hypertension, diabetes
mellitus, kidney disease, or a positive antenatal serology
tests for any of the following infections: HIV, viral hepatitis
B and C, toxoplasmosis, syphilis, rubella, cytomegalovirus,
herpes simplex virus, coxsackie virus, varicella-zoster virus
and parvovirus B19. However, no renal biopsy was per-
formed to exclude any underlying renal disease. Partici-
pants who were lost to follow-up before the sixth month
after delivery were also excluded. For each eligible par-
ticipants, we collected clinical and laboratory data from
day-1 postpartum to 6 months after delivery. Clinical
data included socio-demographic details (age and mari-
tal status), personal and familial history of preeclampsia
or eclampsia, systolic and diastolic blood pressure, body
mass index (BMI), pregnancy characteristics (gravidity,
type of gestation and paternity, gestational age at diag-
nosis of preeclampsia or eclampsia and at delivery,
diagnosis-to-delivery time interval, mode of delivery,
antihypertensive treatment), fetal birth weight and out-
come. Laboratory data included serum and urinary cre-
atinine, and urinary protein. The methods for urine and
blood specimen analysis at the Yaoundé Central Hospital’s
laboratory have been described in details elsewhere [20].
Secondary variables were derived from primary variables
using validated formulas. Estimated glomerular filtration
rate (eGFR) was based on the Cockroft-Gault formula.
Systolic and diastolic blood pressures were monitored
daily during hospitalization, weekly for 6 weeks after dis-
charge, then at 3 months and 6 months after delivery.
Meanwhile serum creatinine and proteinuria (urine pro-
tein to creatinine ratio) were recorded at day-1, every
week from week-2 to week-6, then at 3 months and
6 months after delivery. Additional measurements of
serum creatinine and proteinuria could be done to assist
the management of the patient at the discretion of the at-
tending healthcare team. Such intermediate measurements
are not included in the current study.
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after 20 weeks of pregnancy of blood pressure levels
(systolic/diastolic) of 160/110 mmHg or more, and/or
proteinuria above 5000 mg per day (estimated from the
urine protein to creatinine ratio). Eclampsia was defined
by the onset of seizures in a participant with preeclamp-
sia. Participants, who were first diagnosed with severe
preeclampsia and subsequently convulsed, were assigned
to the eclampsia group. Persisting hypertension was de-
fined by the continuous use of antihypertensive drugs to
maintain blood pressure levels below 140/90 mmHg.
Persisting proteinuria was defined by proteinuria above
200 mg per day (estimated from the urine protein to cre-
atinine ratio) [21]. Renal failure was defined by serum
creatinine levels above 1.1 mg/dl and/or creatinine clear-
ance less than 90 ml/min [22].
Statistical analysis
Data were analyzed with the used of the SAS-STAT®
software v.9.1 for Windows®. Means and standard devia-
tions, median and 25th-75th percentiles, and counts and
percentages were used to express results. The Fisher
exact test, Student t-test and Mann–Whitney U test
were used to compare qualitative and quantitative vari-
ables. Mixed linear regression models were used to
examine changes in blood pressure, proteinuria, serum
creatinine and eGFR during follow-up while adjusting
for baseline and changing levels of potential confounders
during follow-up. Determinants of persisting hyperten-
sion, proteinuria or any of the two at 3 and 6 months
of follow-up were investigated through logistic regres-
sion models. All models were adjusted for age at base-
line, body mass index and systolic blood pressure at
the diagnosis of severe preeclampsia or eclampsia. A
p-value <0.05 was used to indicate statistically signifi-
cant results.
Results
Characteristics of the study population
During the study period, 5610 women were received for
antenatal care and 5765 deliveries performed. Hyper-
tensive disorders were present in 569 (9.8%) pregnant
women including 261 (45.9%) with gestational hyperten-
sion, 125 (21.9%) with chronic hypertension, 117 (20.6%)
with preeclampsia and 66 (11.6%) with eclampsia. Among
those with preeclampsia and eclampsia, 56 (30.6%) con-
sulted after 20 weeks of pregnancy, 53 (28.9%) had super-
imposed preeclampsia/eclampsia and 15 (8.2%) had mild
preeclampsia.
Therefore, a total of 59/569 (10.4%) pregnant women
with severe preeclampsia and eclampsia, fulfilling our in-
clusion criteria were recruited during the study period.
Two pregnant women were lost to follow-up and three
died on day-8, day-12 and 10 weeks after deliveryrespectively for acute kidney injury (could not afford dialy-
sis for financial reasons), pulmonary embolism and pul-
monary edema. Our analytic sample therefore included 54
participants who were followed up for 6 months. They
comprised 37 (68.5%) participants with severe preeclamp-
sia and 17 (31.5%) with eclampsia. As presented in Table 1,
participants with eclampsia were significantly younger,
more likely to deliver prematurely (via emergency caesar-
ean section), to have newborns with low birth weight, to
have a higher frequency of still birth, and to be treated with
parenteral antihypertensive drugs (all p < 0.028).
Trajectories of blood pressure, glomerular filtration rate
and proteinuria during follow-up and prevalence of
persisting abnormal levels at 3 and 6 months
The trajectories of key variables from mixed linear
regressions models, adjusted for baseline age, type of
hypertensive disorders and gestational age at delivery are
depicted in Figure 1. Blood pressure levels and protein-
uria significantly decreased while eGFR significantly in-
creased across visits (all p ≤ 0.002). This pattern was
similar in women with preeclampsia and those with
eclampsia, with no evidence of statistical interaction (all
p ≥ 0.11 for the interaction visit*type of hypertensive dis-
orders); that is the trajectories of blood pressure levels
and proteinuria across follow-up visits did not vary by
type of hypertensive disorder.
Renal function assumed normal range in all women
within three months after delivery while 13 (24.1%) and
10 (18.5%) patients had renal failure based on eGFR and
serum creatinine respectively on day-1 post-partum. The
prevalence of proteinuria decreased gradually with 26
(48.1%), 17 (31.5%) and 1 (1.8%) patients presenting per-
sisting proteinuria at 6 weeks, 3 months and 6 months
respectively. Similarly, hypertension prevalence decreased
gradually with 23 (42.6%), 15 (27.8%) and 8 (14.8%) pa-
tients remaining hypertensive at 6 weeks, 3 months and
6 months respectively (Table 1).
Determinants of hypertension and proteinuria
In age, systolic blood pressure and body mass index ad-
justed logistic regression models (Table 2), advanced age
[odd ratio per one year 1.20 (95% confidence interval:
1.03-1.39)], and higher body mass index [1.20 (1.03-1.41)
per kg/m2] were associated with increased risk of per-
sisting hypertension at three months, meanwhile higher
gestational age at delivery [0.71 (0.53-0.96) per week]
and high fetal birth weight [0.41 (0.19-0.87) per 500 g
higher] were associated with lower risk of persisting
hypertension at three months. Higher fetal birth weight
was also associated with lower risk of persisting protein-
uria at 3 months [0.60 (0.37-0.98) per 500 g higher]
while higher baseline urinary protein excretion was asso-
ciated with increased risk of persisting proteinuria at
Table 1 Characteristics overall and by diagnostic categories
Characteristics Overall Severe preeclampsia Eclampsia p
n 54 37 17
Age, years (SD) 26.3 (6.6) 27.6 (6.5) 23.3 (5.9) 0.025
Married (%) 23 (42.6) 17 (45.9) 6 (35.3) 0.56
Weight, kg (SD) 76.9 (14.6) 78.4 (14.4) 73.6 (14.8) 0.27
Body mass index, Kg/m2 (SD) 26.3 (4.8) 26.7 (4.7) 25.4 (5.2) 0.37
Systolic blood pressure, mmHg (SD) 167.2 (19.6) 166.6 (16.9) 168.7 (25.1) 0.71
Diastolic blood pressure, mmHg (SD) 104.1 (17.6) 104.6 (17.2) 102.9 (19.0) 0.75
Personal history, n (%) 9 (16.7) 9 (24.3) 0 0.044
Family history, n (%) 2 (3.7) 2 (5.4) 0 >0.99
Gravidity, median (min-max) 1 (1–3) 2 (1–4) 1 (1–1) 0.018
Para, median (min-max) 1 (0–2) 1 (1–2) 1 (0–1) 0.007
Premature, median (min-max) 0 (0–1) 0 (0–1) 0 (0–1) 0.72
Aborted, median (min-max) 0 (0–1) 0 (0–1) 0 (0–1) 0.88
Alive, median (min-max) 1 (1–2) 1 (1–3) 1 (1–1) 0.0005
Primipartenity, n (%) 37 (68.5) 22 (59.4) 15 (88.2) 0.06
Single gestation, n (%) 49 (90.1) 34 (9.9) 15 (88.2) 0.64
Gestational age at diagnosis, week (SD) 34.3 (6.0) 34.8 (5.8) 33.3 (6.5) 0.42
Gestational age at delivery, week (SD) 36.9 (3.5) 37.6 (2.8) 35.4 (4.2) 0.028
Delivery – diagnosis time, day (median, min-max) 0 (0–20) 0 (0–20) 0 (0–17) 0.18
Time to delivery from diagnosis >1 week, n (%) 14 (25.9) 11 (29.7) 3 (17.6) 0.51
Vaginal delivery, n (%) 31 (57.4) 20 (54) 11 (64.7) 0.56
Birth weight, g (SD) 2732 (691) 2938 (586) 2286 (708) 0.0008
Foetal outcome, n (%) <0.0001
Death 10 (18.5) 2 (5.4) 8 (47)
Alive 44 (81.5) 35 (94.6) 9 (53)
Treatment received
Methyl-dopa tablet, n (%) 47 (87) 31 (83.8) 16 (94.1) 0.41
Nicardipine injection, n (%) 35 (64.8) 19 (51.3) 16 (94.1) 0.002
Nicardipine tablet, n (%) 32 (59.2) 23 (62.2) 9 (52.9) 0.56
Labetalol tablet, n (%) 4 (7.4) 3 (8.1) 1 (5.9) >0.99
Diazepam injection, n (%) 5 (9.2) 0 5 (29.4) 0.002
Clorazepam tablet, n (%) 10 (18.5) 4 (10.8) 6 (35.3) 0.06
MgSO4 injection, n (%) 54 (100) 37 (100) 17(100) NA
Outcomes
Persisting hypertension at M3, n (%) 15 (27.8) 11 (29.7) 4 (23.5) 0.75
Persisting hypertension at M6, n (%) 8 (14.8) 6 (16.2) 2 (11.8) >0.99
Persisting proteinuria at M3, n (%) 17 (31.5) 8 (21.6) 9 (52.9) 0.03
Persisting proteinuria at M6, n (%) 1 (1.8) 1 (2.7) 0 >0.99
Persisting hypertension or proteinuria at M3, n (%) 26 (48.1) 16 (43.2) 10 (58.8) 0.38
Persisting hypertension or proteinuria at M6, n (%) 9 (16.7) 7 (18.9) 2 (11.8) 0.70
M – Month; SD – Standard deviation.
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composite outcome of persisting hypertension or pro-
teinuria at 3 months [5.83 (1.43-23.84)]. Advanced ageand higher BMI were the main determinants of the com-
posite outcome of persisting hypertension or proteinuria
at 6 months (Table 2).
Figure 1 Time trend in blood pressure and kidney function parameters during follow-up. Figures are from mixed linear regression models
with adjustment for baseline age, visit, diagnosis type and gestational age at delivery. Panels: A – Systolic and diastolic blood pressure; B – Serum
creatinine; C – Estimated glomerular filtration rate; D – Estimated proteinuria.
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Our study has revealed in this group of women with
pre-eclampsia and eclampsia, the high prevalence of per-
sisting proteinuria and hypertension beyond the postpar-
tum period and full recovery of renal function within the
same period. Persisting hypertension and/or proteinuria
correlated with increasing age and BMI, low gestational
age at delivery, low fetal birth weight, and increased pro-
teinuria at delivery, while baseline hypertensive disorder
had no effect on the trajectories of blood pressure levels
and proteinuria during follow-up. These results suggest
that pregnant women with hypertensive disorders in this
setting should be followed up for a much longer period
after delivery, and where possible, investigations should
be conducted to capture and adequately treat any under-
lying renal disease [6,8,11,12,16,17].
About a quarter of participants had acute kidney
injury (acute renal failure) at delivery which complete
resolved within the postpartum period as reported else-
where [16,23]. This prevalence was lower than the 35.3%reported by Prakash et al. in India in their study on
the spectrum of acute renal failure in late pregnancy
[7]. Glomerular endotheliosis, which occurs in pre-
eclampsia and eclampsia, decreases glomerular filtra-
tion rate and renal flow, and increases renal vascular
resistance, predisposing patients to acute renal failure
[6,24]. This renal involvement may persist for several
years after delivery, indicating that women with pre-
eclampsia or eclampsia should have extended nephro-
logical follow-up.
The high prevalence of persisting hypertension ob-
served among our study participants was associated
with advanced age, increased BMI, low gestational age
at delivery, low fetal birth weight and severity of pro-
teinuria at delivery as reported elsewhere [15,23]. How-
ever, there have also been conflicting reports, with some
suggesting a near-normalization of blood pressure levels
within 4 weeks from delivery, and others observing much
lower rates of hypertension at 6 weeks post-delivery
[15,23]. During preeclampsia and eclampsia, generalized
Table 2 Determinants of three and six month’s outcomes of hypertension and proteinuria
Variables Persisting hypertension
at 3 months
Persisting proteinuria
at 3 months
Persisting hypertension or
proteinuria at 3 months
Persisting hypertension or
proteinuria at 6 months
Age, per year 1.20 (1.03-1.39) 0.98 (0.89-1.09) 1.10 (0.99-1.22) 1.32 (1.03-1.70)
Marital status, single 1.20 (0.33-6.38) 0.69 (0.21-2.32) 0.53 (0.16-1.76) 1.24 (0.12-12.80)
BMI, per kg/m2 1.20 (1.03-1.41) 1.02 (0.80-1.17) 1.07 (0.93-1.23) 1.31 (1.07-1.60)
SBP baseline, per mmHg 0.98 (0.94-1.02) 1.01 (0.98-1.03) 0.99 (0.96-1.02) 1.01 (0.97-1.06)
DBP baseline, per mmHg 0.98 (0.91-1.05) 1.01 (0.96-1.06) 1.01 (0.96-1.06) 1.06 (0.93-1.20)
Severe pre-eclampsia, yes vs. no 0.42 (0.06-2.78) 0.20 (0.06-0.84) 0.22 (0.05-0.96) 0.99 (0.06-17.11)
Gravidity, per unit 1.01 (0.66-1.55) 0.78 (0.48-1.21) 1.05 (0.71-1.54) 1.30 (0.75-2.26)
Primipartenity, yes vs. no 0.64 (0.10-3.88) 0.83 (0.18-3.96) 1.10 (0.24-5.01) 0.88 (0.09-8.38)
Gestational age at delivery, per week 0.71 (0.53-0.96) 0.92 (0.77-1.09) 0.81 (0.66-0.99) 0.85 (0.62-1.15)
Time to delivery < 1 week, yes vs no 0.24 (0.03-1.75) 4.23 (0.67-30.47) 1.53 (0.31-7.51) 5.10 (0.27-97.86)
Route of delivery, CS 0.51 (0.10-2.61) 3.42 (0.92-12.64) 1.26 (0.37-4.25) 2.35 (0.21-25.79)
Birthweight (per 500 g) 0.41 (0.19-0.87) 0.60 (0.37-0.98) 0.49 (0.30-0.82) 0.92 (0.42-1.99)
Fetal outcome (alive) 3.05 (0.43-21.6) 1.57 (0.36-6.86) 2.42 (0.53-10.95) 0.46 (0.01-18.48)
Proteinuria at day 1, per unit 4.59 (1.27-16.55) 8.48 (1.36-52.79) 5.83 (1.43-23.84) 1.46 (0.30-6.80)
Creatinine at day 1, per unit 0.93 (0.15-5.87) 1.86 (0.62-5.54) 1.42 (0.42-4.76) 4.51 (0.45-45.31)
All models are adjusted for baseline age, SBP and BMI.
BMI – Body mass index; CS – Caesarean section; DBP – Diastolic blood pressure; SBP – Systolic blood pressure.
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creasing the long-term risk of hypertension from age-
related systemic vascular stiffness with or without
low initial nephron number [6,16,17,24]. In normal preg-
nancy, there are hemodynamic changes which activate the
renin-angiotensin-aldosterone system, resulting in water
and sodium retention, thus increase the BMI in later preg-
nancy [25]. Their association with generalized vasocon-
striction during preeclampsia could explain the persistence
of hypertension beyond the post-partum period.
We observed persisting near-complete resolution of
proteinuria at six months post-partum as reported
elsewhere [14,23]. Studies have reported an increase
concentration of circulating soluble fms-like tyrosine
kinase-1 in relation with glomerular endotheliosis and
proteinuria. The later may persist many years after pre-
eclampsia, in the form of micro- or macroalbuminuria,
suggesting a slower resolution of pregnancy-related renal
changes [6,16,17].
This study has some limitations including the absence
of uric acid measurements, and liver evaluation to diag-
nose some complications like HELLP (hemolysis, elevated
liver enzymes, low platelet) syndrome. Furthermore, our
sample size may have affected our power for detecting
some significant associations. Nevertheless, this study has
the advantage of reporting, perhaps for the first time,
the six month follow-up after delivery, of women with
preeclampsia and eclampsia in the Sub-Saharan African
setting without evidence of underlying renal disease
according to the renal assessment done before pregnancyand 20 weeks of gestation. Furthermore, we took ad-
vantage of robust statistical methods to carefully in-
vestigate the time changes in key study parameters
during follow-up, as well as the effects of their potential
correlates.
Conclusions
We have reported a high prevalence of hypertension and
proteinuria beyond the postpartum period in women
with pre-eclampsia and eclampsia in this setting. These
patterns have been associated with increased future risk
of chronic hypertension, ESRD and cardiovascular mor-
tality [6,8,17]. Therefore, we suggest the need of an ex-
tended follow-up of these women beyond the postpartum
period, particularly the older, those with high BMI, low
gestational age at delivery, low fetal birth weight and in-
creased proteinuria at delivery. This will allow the imple-
mentation of measures delay the onset and progression
complications, as well as early detection, investigation and
treatment of those who, in spite of preventive measures,
will still develop those complications.
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